6 of the world's top 20 pharmaceutical companies are standardizing on Veeva Vault QMS

BARCELONA, Spain, Jan. XNUMX / PRNewswire / - More than 175 companies use Vault QMS to optimize end-to-end quality processes

Leading companies continue to rely on the modernization of quality management. In light of this development, six of the world's top 20 pharmaceutical companies have partnered with Veeva Systems (NYSE: VEEV) closed to with Veeva Vault QMS to achieve greater efficiency and better transparency throughout the company. A growing number of companies, including more than 175 biopharmaceutical, contract manufacturing, generic and medical device companies, have adopted Vault QMS to streamline and automate quality processes.

"As a long-term partner, Veeva works closely with us on our digital quality initiatives," said Nicolás Maldonado, Senior Director, Quality Policies and Systems at Gilead Sciences. "We are excited to introduce Veeva Vault QMS to simplify, harmonize and automate quality processes in several strategic business areas within Gilead."

More and more companies are using Veeva's modern cloud solutions to bring together quality processes for more transparency and real-time tracking across global locations, manufacturing partners and suppliers. Industry leaders partner with Veeva to simplify quality management and increase operational efficiency with a unified quality platform.

"Organizations want a trusted partner who is focused on customer success as they conduct digital quality transformation," said Mike Jovanis, vice president, Veeva Vault Quality. "Veeva is committed to delivering customer-centric innovation in product development and manufacturing, and will continue to do so."

Veeva's continuous innovations help customers proactively manage quality and increase agility. New features introduced to Vault QMS last year include:

  • Seamless connection between Vault QMS and Veeva Vault Registrations to reduce the cycle time and increase the transparency of the change control after the market launch
  • Further developments in quality risk management (QRM), including the FMEA methodology to support the proactive identification and mitigation of risks
  • Fully automated process for external auditors such as CMOs and suppliers to react to audit results directly in the system

Vault QMS is part of the Veeva Vault Quality Suite, which Veeva Vault QualityDocs, Veeva Vault Training, Veeva Vault Station Manager and Veeva Vault Product Surveillance includes and automates and harmonizes quality processes worldwide.

In a further announcement, Veeva announced today that Bluepharma has selected the Vault Quality Suite to unify its global quality management. Read the press release for more information.

Learn more about the Vault Quality Suite on the upcoming Veeva R&D and Quality Summit Connect Europe on May 20, 2021. The online event is open to professionals from the life science industry. Register and stay up to date on program details below veeva.com/Summit.

additional information
For more information on Veeva Vault QMS, please visit: veeva.com/QMS
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems Follow @veeva_eu on Twitter: twitter.com/veeva_eu

About Veeva Systems

Veeva is the world's leading provider of cloud software for the life science industry. Devoted to innovation, product quality and customer success, Veeva serves more than 975 customers, from the world's largest pharmaceutical companies to emerging biotech companies. As a not-for-profit, Veeva is committed to aligning the interests of all stakeholders, including customers, employees, shareholders and the industries it serves. For more information, visit veeva.com/eu.

Forward-looking statements

This release contains forward-looking statements, including market demand for and acceptance of Veeva's products and services, results from the use of Veeva's products and services, and the general business situation (including the ongoing effects of COVID-19), particularly in Life -Science industry. All forward-looking statements contained in this press release are based on Veeva's historical performance and current plans, estimates and expectations of the company and are no representation that these plans, estimates or expectations will actually be achieved. These forward-looking statements represent Veeva's expectations as of the date of this press release. Later events could cause these expectations to change and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that could cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva's financial results are under the headings “Risk Factors” and “Management's Discussion and Analysis of Financial Condition and Results of Operations” in the company's filing on Form 10-K for the period included until January 31, 2021. This is on the company's website at veeva.com in the Investors section and on the SEC's website at sec.gov to find. Additional information about potential risks that could affect actual results will be contained in other documents that Veeva may receive from time to time
files with the SEC.

Contact:

Deivis MercadoVeeva Systems925-226-8821deivis.mercado@veeva.com

Logo - https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg